Safety, Tolerability, and Pharmacokinetics Study of ATH-1020

NCT05169671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ATH-1020
DRUG: Placebo

Sponsor

LeonaBio

Collaborators

[object Object]
[object Object]